 | • レポートコード：MRC2-11QY09085 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は呼吸器合胞体ウイルス付着糖タンパク質のグローバル市場について調査・分析したレポートです。種類別（VIS-RSV、TRL-3D3、AX-14、MVA-RSV、その他）市場規模、用途別（クリニック、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別呼吸器合胞体ウイルス付着糖タンパク質の競争状況、市場シェア ・世界の呼吸器合胞体ウイルス付着糖タンパク質市場：種類別市場規模 2015年-2020年（VIS-RSV、TRL-3D3、AX-14、MVA-RSV、その他） ・世界の呼吸器合胞体ウイルス付着糖タンパク質市場：種類別市場規模予測 2021年-2026年（VIS-RSV、TRL-3D3、AX-14、MVA-RSV、その他） ・世界の呼吸器合胞体ウイルス付着糖タンパク質市場：用途別市場規模 2015年-2020年（クリニック、病院、その他） ・世界の呼吸器合胞体ウイルス付着糖タンパク質市場：用途別市場規模予測 2021年-2026年（クリニック、病院、その他） ・北米の呼吸器合胞体ウイルス付着糖タンパク質市場分析：米国、カナダ ・ヨーロッパの呼吸器合胞体ウイルス付着糖タンパク質市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの呼吸器合胞体ウイルス付着糖タンパク質市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の呼吸器合胞体ウイルス付着糖タンパク質市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの呼吸器合胞体ウイルス付着糖タンパク質市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Agilvax, Inc.、Bavarian Nordic A/S、Emergent BioSolutions Inc.、F. Hoffmann-La Roche Ltd.、Trellis Bioscience, Inc. ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Respiratory Syncytial Virus Attachment Glycoprotein Market
The global Respiratory Syncytial Virus Attachment Glycoprotein market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Respiratory Syncytial Virus Attachment Glycoprotein Scope and Market Size
Respiratory Syncytial Virus Attachment Glycoprotein market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Respiratory Syncytial Virus Attachment Glycoprotein market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Respiratory Syncytial Virus Attachment Glycoprotein market is segmented into
VIS-RSV
TRL-3D3
AX-14
MVA-RSV
Others
Segment by Application, the Respiratory Syncytial Virus Attachment Glycoprotein market is segmented into
Clinic
Hospital
Others
Regional and Country-level Analysis
The Respiratory Syncytial Virus Attachment Glycoprotein market is analysed and market size information is provided by regions (countries).
The key regions covered in the Respiratory Syncytial Virus Attachment Glycoprotein market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Respiratory Syncytial Virus Attachment Glycoprotein Market Share Analysis
Respiratory Syncytial Virus Attachment Glycoprotein market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Respiratory Syncytial Virus Attachment Glycoprotein business, the date to enter into the Respiratory Syncytial Virus Attachment Glycoprotein market, Respiratory Syncytial Virus Attachment Glycoprotein product introduction, recent developments, etc.
The major vendors covered:
Agilvax, Inc.
Bavarian Nordic A/S
Emergent BioSolutions Inc.
F. Hoffmann-La Roche Ltd.
Trellis Bioscience, Inc.
…
1 Study Coverage
1.1 Respiratory Syncytial Virus Attachment Glycoprotein Product Introduction
1.2 Market Segments
1.3 Key Respiratory Syncytial Virus Attachment Glycoprotein Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Respiratory Syncytial Virus Attachment Glycoprotein Market Size Growth Rate by Type
1.4.2 VIS-RSV
1.4.3 TRL-3D3
1.4.4 AX-14
1.4.5 MVA-RSV
1.4.6 Others
1.5 Market by Application
1.5.1 Global Respiratory Syncytial Virus Attachment Glycoprotein Market Size Growth Rate by Application
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Respiratory Syncytial Virus Attachment Glycoprotein Market Size, Estimates and Forecasts
2.1.1 Global Respiratory Syncytial Virus Attachment Glycoprotein Revenue 2015-2026
2.1.2 Global Respiratory Syncytial Virus Attachment Glycoprotein Sales 2015-2026
2.2 Global Respiratory Syncytial Virus Attachment Glycoprotein, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Respiratory Syncytial Virus Attachment Glycoprotein Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Respiratory Syncytial Virus Attachment Glycoprotein Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Respiratory Syncytial Virus Attachment Glycoprotein Competitor Landscape by Players
3.1 Respiratory Syncytial Virus Attachment Glycoprotein Sales by Manufacturers
3.1.1 Respiratory Syncytial Virus Attachment Glycoprotein Sales by Manufacturers (2015-2020)
3.1.2 Respiratory Syncytial Virus Attachment Glycoprotein Sales Market Share by Manufacturers (2015-2020)
3.2 Respiratory Syncytial Virus Attachment Glycoprotein Revenue by Manufacturers
3.2.1 Respiratory Syncytial Virus Attachment Glycoprotein Revenue by Manufacturers (2015-2020)
3.2.2 Respiratory Syncytial Virus Attachment Glycoprotein Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Respiratory Syncytial Virus Attachment Glycoprotein Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Respiratory Syncytial Virus Attachment Glycoprotein Revenue in 2019
3.2.5 Global Respiratory Syncytial Virus Attachment Glycoprotein Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Respiratory Syncytial Virus Attachment Glycoprotein Price by Manufacturers
3.4 Respiratory Syncytial Virus Attachment Glycoprotein Manufacturing Base Distribution, Product Types
3.4.1 Respiratory Syncytial Virus Attachment Glycoprotein Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Respiratory Syncytial Virus Attachment Glycoprotein Product Type
3.4.3 Date of International Manufacturers Enter into Respiratory Syncytial Virus Attachment Glycoprotein Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Respiratory Syncytial Virus Attachment Glycoprotein Market Size by Type (2015-2020)
4.1.1 Global Respiratory Syncytial Virus Attachment Glycoprotein Sales by Type (2015-2020)
4.1.2 Global Respiratory Syncytial Virus Attachment Glycoprotein Revenue by Type (2015-2020)
4.1.3 Respiratory Syncytial Virus Attachment Glycoprotein Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Respiratory Syncytial Virus Attachment Glycoprotein Market Size Forecast by Type (2021-2026)
4.2.1 Global Respiratory Syncytial Virus Attachment Glycoprotein Sales Forecast by Type (2021-2026)
4.2.2 Global Respiratory Syncytial Virus Attachment Glycoprotein Revenue Forecast by Type (2021-2026)
4.2.3 Respiratory Syncytial Virus Attachment Glycoprotein Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Respiratory Syncytial Virus Attachment Glycoprotein Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Respiratory Syncytial Virus Attachment Glycoprotein Market Size by Application (2015-2020)
5.1.1 Global Respiratory Syncytial Virus Attachment Glycoprotein Sales by Application (2015-2020)
5.1.2 Global Respiratory Syncytial Virus Attachment Glycoprotein Revenue by Application (2015-2020)
5.1.3 Respiratory Syncytial Virus Attachment Glycoprotein Price by Application (2015-2020)
5.2 Respiratory Syncytial Virus Attachment Glycoprotein Market Size Forecast by Application (2021-2026)
5.2.1 Global Respiratory Syncytial Virus Attachment Glycoprotein Sales Forecast by Application (2021-2026)
5.2.2 Global Respiratory Syncytial Virus Attachment Glycoprotein Revenue Forecast by Application (2021-2026)
5.2.3 Global Respiratory Syncytial Virus Attachment Glycoprotein Price Forecast by Application (2021-2026)
6 North America
6.1 North America Respiratory Syncytial Virus Attachment Glycoprotein by Country
6.1.1 North America Respiratory Syncytial Virus Attachment Glycoprotein Sales by Country
6.1.2 North America Respiratory Syncytial Virus Attachment Glycoprotein Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Respiratory Syncytial Virus Attachment Glycoprotein Market Facts & Figures by Type
6.3 North America Respiratory Syncytial Virus Attachment Glycoprotein Market Facts & Figures by Application
7 Europe
7.1 Europe Respiratory Syncytial Virus Attachment Glycoprotein by Country
7.1.1 Europe Respiratory Syncytial Virus Attachment Glycoprotein Sales by Country
7.1.2 Europe Respiratory Syncytial Virus Attachment Glycoprotein Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Respiratory Syncytial Virus Attachment Glycoprotein Market Facts & Figures by Type
7.3 Europe Respiratory Syncytial Virus Attachment Glycoprotein Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Respiratory Syncytial Virus Attachment Glycoprotein by Region
8.1.1 Asia Pacific Respiratory Syncytial Virus Attachment Glycoprotein Sales by Region
8.1.2 Asia Pacific Respiratory Syncytial Virus Attachment Glycoprotein Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Respiratory Syncytial Virus Attachment Glycoprotein Market Facts & Figures by Type
8.3 Asia Pacific Respiratory Syncytial Virus Attachment Glycoprotein Market Facts & Figures by Application
9 Latin America
9.1 Latin America Respiratory Syncytial Virus Attachment Glycoprotein by Country
9.1.1 Latin America Respiratory Syncytial Virus Attachment Glycoprotein Sales by Country
9.1.2 Latin America Respiratory Syncytial Virus Attachment Glycoprotein Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Respiratory Syncytial Virus Attachment Glycoprotein Market Facts & Figures by Type
9.3 Central & South America Respiratory Syncytial Virus Attachment Glycoprotein Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Respiratory Syncytial Virus Attachment Glycoprotein by Country
10.1.1 Middle East and Africa Respiratory Syncytial Virus Attachment Glycoprotein Sales by Country
10.1.2 Middle East and Africa Respiratory Syncytial Virus Attachment Glycoprotein Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Respiratory Syncytial Virus Attachment Glycoprotein Market Facts & Figures by Type
10.3 Middle East and Africa Respiratory Syncytial Virus Attachment Glycoprotein Market Facts & Figures by Application
11 Company Profiles
11.1 Agilvax, Inc.
11.1.1 Agilvax, Inc. Corporation Information
11.1.2 Agilvax, Inc. Description and Business Overview
11.1.3 Agilvax, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Agilvax, Inc. Respiratory Syncytial Virus Attachment Glycoprotein Products Offered
11.1.5 Agilvax, Inc. Related Developments
11.2 Bavarian Nordic A/S
11.2.1 Bavarian Nordic A/S Corporation Information
11.2.2 Bavarian Nordic A/S Description and Business Overview
11.2.3 Bavarian Nordic A/S Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bavarian Nordic A/S Respiratory Syncytial Virus Attachment Glycoprotein Products Offered
11.2.5 Bavarian Nordic A/S Related Developments
11.3 Emergent BioSolutions Inc.
11.3.1 Emergent BioSolutions Inc. Corporation Information
11.3.2 Emergent BioSolutions Inc. Description and Business Overview
11.3.3 Emergent BioSolutions Inc. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Emergent BioSolutions Inc. Respiratory Syncytial Virus Attachment Glycoprotein Products Offered
11.3.5 Emergent BioSolutions Inc. Related Developments
11.4 F. Hoffmann-La Roche Ltd.
11.4.1 F. Hoffmann-La Roche Ltd. Corporation Information
11.4.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
11.4.3 F. Hoffmann-La Roche Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 F. Hoffmann-La Roche Ltd. Respiratory Syncytial Virus Attachment Glycoprotein Products Offered
11.4.5 F. Hoffmann-La Roche Ltd. Related Developments
11.5 Trellis Bioscience, Inc.
11.5.1 Trellis Bioscience, Inc. Corporation Information
11.5.2 Trellis Bioscience, Inc. Description and Business Overview
11.5.3 Trellis Bioscience, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Trellis Bioscience, Inc. Respiratory Syncytial Virus Attachment Glycoprotein Products Offered
11.5.5 Trellis Bioscience, Inc. Related Developments
11.1 Agilvax, Inc.
11.1.1 Agilvax, Inc. Corporation Information
11.1.2 Agilvax, Inc. Description and Business Overview
11.1.3 Agilvax, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Agilvax, Inc. Respiratory Syncytial Virus Attachment Glycoprotein Products Offered
11.1.5 Agilvax, Inc. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Respiratory Syncytial Virus Attachment Glycoprotein Market Estimates and Projections by Region
12.1.1 Global Respiratory Syncytial Virus Attachment Glycoprotein Sales Forecast by Regions 2021-2026
12.1.2 Global Respiratory Syncytial Virus Attachment Glycoprotein Revenue Forecast by Regions 2021-2026
12.2 North America Respiratory Syncytial Virus Attachment Glycoprotein Market Size Forecast (2021-2026)
12.2.1 North America: Respiratory Syncytial Virus Attachment Glycoprotein Sales Forecast (2021-2026)
12.2.2 North America: Respiratory Syncytial Virus Attachment Glycoprotein Revenue Forecast (2021-2026)
12.2.3 North America: Respiratory Syncytial Virus Attachment Glycoprotein Market Size Forecast by Country (2021-2026)
12.3 Europe Respiratory Syncytial Virus Attachment Glycoprotein Market Size Forecast (2021-2026)
12.3.1 Europe: Respiratory Syncytial Virus Attachment Glycoprotein Sales Forecast (2021-2026)
12.3.2 Europe: Respiratory Syncytial Virus Attachment Glycoprotein Revenue Forecast (2021-2026)
12.3.3 Europe: Respiratory Syncytial Virus Attachment Glycoprotein Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Respiratory Syncytial Virus Attachment Glycoprotein Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Respiratory Syncytial Virus Attachment Glycoprotein Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Respiratory Syncytial Virus Attachment Glycoprotein Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Respiratory Syncytial Virus Attachment Glycoprotein Market Size Forecast by Region (2021-2026)
12.5 Latin America Respiratory Syncytial Virus Attachment Glycoprotein Market Size Forecast (2021-2026)
12.5.1 Latin America: Respiratory Syncytial Virus Attachment Glycoprotein Sales Forecast (2021-2026)
12.5.2 Latin America: Respiratory Syncytial Virus Attachment Glycoprotein Revenue Forecast (2021-2026)
12.5.3 Latin America: Respiratory Syncytial Virus Attachment Glycoprotein Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Respiratory Syncytial Virus Attachment Glycoprotein Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Respiratory Syncytial Virus Attachment Glycoprotein Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Respiratory Syncytial Virus Attachment Glycoprotein Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Respiratory Syncytial Virus Attachment Glycoprotein Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Respiratory Syncytial Virus Attachment Glycoprotein Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Respiratory Syncytial Virus Attachment Glycoprotein Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Respiratory Syncytial Virus Attachment Glycoprotein Market Segments
Table 2. Ranking of Global Top Respiratory Syncytial Virus Attachment Glycoprotein Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Respiratory Syncytial Virus Attachment Glycoprotein Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of VIS-RSV
Table 5. Major Manufacturers of TRL-3D3
Table 6. Major Manufacturers of AX-14
Table 7. Major Manufacturers of MVA-RSV
Table 8. Major Manufacturers of Others
Table 9. Global Respiratory Syncytial Virus Attachment Glycoprotein Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Respiratory Syncytial Virus Attachment Glycoprotein Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Respiratory Syncytial Virus Attachment Glycoprotein Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Respiratory Syncytial Virus Attachment Glycoprotein Sales Market Share by Regions (2015-2020)
Table 13. Global Respiratory Syncytial Virus Attachment Glycoprotein Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Respiratory Syncytial Virus Attachment Glycoprotein Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Respiratory Syncytial Virus Attachment Glycoprotein Sales Share by Manufacturers (2015-2020)
Table 16. Global Respiratory Syncytial Virus Attachment Glycoprotein Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Respiratory Syncytial Virus Attachment Glycoprotein by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Respiratory Syncytial Virus Attachment Glycoprotein as of 2019)
Table 18. Respiratory Syncytial Virus Attachment Glycoprotein Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Respiratory Syncytial Virus Attachment Glycoprotein Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Respiratory Syncytial Virus Attachment Glycoprotein Price (2015-2020) (USD/Pcs)
Table 21. Respiratory Syncytial Virus Attachment Glycoprotein Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Respiratory Syncytial Virus Attachment Glycoprotein Product Type
Table 23. Date of International Manufacturers Enter into Respiratory Syncytial Virus Attachment Glycoprotein Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Respiratory Syncytial Virus Attachment Glycoprotein Sales by Type (2015-2020) (K Pcs)
Table 26. Global Respiratory Syncytial Virus Attachment Glycoprotein Sales Share by Type (2015-2020)
Table 27. Global Respiratory Syncytial Virus Attachment Glycoprotein Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Respiratory Syncytial Virus Attachment Glycoprotein Revenue Share by Type (2015-2020)
Table 29. Respiratory Syncytial Virus Attachment Glycoprotein Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Respiratory Syncytial Virus Attachment Glycoprotein Sales by Application (2015-2020) (K Pcs)
Table 31. Global Respiratory Syncytial Virus Attachment Glycoprotein Sales Share by Application (2015-2020)
Table 32. North America Respiratory Syncytial Virus Attachment Glycoprotein Sales by Country (2015-2020) (K Pcs)
Table 33. North America Respiratory Syncytial Virus Attachment Glycoprotein Sales Market Share by Country (2015-2020)
Table 34. North America Respiratory Syncytial Virus Attachment Glycoprotein Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Respiratory Syncytial Virus Attachment Glycoprotein Revenue Market Share by Country (2015-2020)
Table 36. North America Respiratory Syncytial Virus Attachment Glycoprotein Sales by Type (2015-2020) (K Pcs)
Table 37. North America Respiratory Syncytial Virus Attachment Glycoprotein Sales Market Share by Type (2015-2020)
Table 38. North America Respiratory Syncytial Virus Attachment Glycoprotein Sales by Application (2015-2020) (K Pcs)
Table 39. North America Respiratory Syncytial Virus Attachment Glycoprotein Sales Market Share by Application (2015-2020)
Table 40. Europe Respiratory Syncytial Virus Attachment Glycoprotein Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Respiratory Syncytial Virus Attachment Glycoprotein Sales Market Share by Country (2015-2020)
Table 42. Europe Respiratory Syncytial Virus Attachment Glycoprotein Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Respiratory Syncytial Virus Attachment Glycoprotein Revenue Market Share by Country (2015-2020)
Table 44. Europe Respiratory Syncytial Virus Attachment Glycoprotein Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Respiratory Syncytial Virus Attachment Glycoprotein Sales Market Share by Type (2015-2020)
Table 46. Europe Respiratory Syncytial Virus Attachment Glycoprotein Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Respiratory Syncytial Virus Attachment Glycoprotein Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Respiratory Syncytial Virus Attachment Glycoprotein Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Respiratory Syncytial Virus Attachment Glycoprotein Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Respiratory Syncytial Virus Attachment Glycoprotein Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Respiratory Syncytial Virus Attachment Glycoprotein Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Respiratory Syncytial Virus Attachment Glycoprotein Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Respiratory Syncytial Virus Attachment Glycoprotein Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Respiratory Syncytial Virus Attachment Glycoprotein Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Respiratory Syncytial Virus Attachment Glycoprotein Sales Market Share by Application (2015-2020)
Table 56. Latin America Respiratory Syncytial Virus Attachment Glycoprotein Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Respiratory Syncytial Virus Attachment Glycoprotein Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Respiratory Syncytial Virus Attachment Glycoprotein Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Respiratory Syncytial Virus Attachment Glycoprotein Revenue Market Share by Country (2015-2020)
Table 60. Latin America Respiratory Syncytial Virus Attachment Glycoprotein Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Respiratory Syncytial Virus Attachment Glycoprotein Sales Market Share by Type (2015-2020)
Table 62. Latin America Respiratory Syncytial Virus Attachment Glycoprotein Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Respiratory Syncytial Virus Attachment Glycoprotein Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Respiratory Syncytial Virus Attachment Glycoprotein Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Respiratory Syncytial Virus Attachment Glycoprotein Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Respiratory Syncytial Virus Attachment Glycoprotein Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Respiratory Syncytial Virus Attachment Glycoprotein Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Respiratory Syncytial Virus Attachment Glycoprotein Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Respiratory Syncytial Virus Attachment Glycoprotein Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Respiratory Syncytial Virus Attachment Glycoprotein Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Respiratory Syncytial Virus Attachment Glycoprotein Sales Market Share by Application (2015-2020)
Table 72. Agilvax, Inc. Corporation Information
Table 73. Agilvax, Inc. Description and Major Businesses
Table 74. Agilvax, Inc. Respiratory Syncytial Virus Attachment Glycoprotein Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Agilvax, Inc. Product
Table 76. Agilvax, Inc. Recent Development
Table 77. Bavarian Nordic A/S Corporation Information
Table 78. Bavarian Nordic A/S Description and Major Businesses
Table 79. Bavarian Nordic A/S Respiratory Syncytial Virus Attachment Glycoprotein Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Bavarian Nordic A/S Product
Table 81. Bavarian Nordic A/S Recent Development
Table 82. Emergent BioSolutions Inc. Corporation Information
Table 83. Emergent BioSolutions Inc. Description and Major Businesses
Table 84. Emergent BioSolutions Inc. Respiratory Syncytial Virus Attachment Glycoprotein Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Emergent BioSolutions Inc. Product
Table 86. Emergent BioSolutions Inc. Recent Development
Table 87. F. Hoffmann-La Roche Ltd. Corporation Information
Table 88. F. Hoffmann-La Roche Ltd. Description and Major Businesses
Table 89. F. Hoffmann-La Roche Ltd. Respiratory Syncytial Virus Attachment Glycoprotein Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. F. Hoffmann-La Roche Ltd. Product
Table 91. F. Hoffmann-La Roche Ltd. Recent Development
Table 92. Trellis Bioscience, Inc. Corporation Information
Table 93. Trellis Bioscience, Inc. Description and Major Businesses
Table 94. Trellis Bioscience, Inc. Respiratory Syncytial Virus Attachment Glycoprotein Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Trellis Bioscience, Inc. Product
Table 96. Trellis Bioscience, Inc. Recent Development
Table 97. Global Respiratory Syncytial Virus Attachment Glycoprotein Sales Forecast by Regions (2021-2026) (K Pcs)
Table 98. Global Respiratory Syncytial Virus Attachment Glycoprotein Sales Market Share Forecast by Regions (2021-2026)
Table 99. Global Respiratory Syncytial Virus Attachment Glycoprotein Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 100. Global Respiratory Syncytial Virus Attachment Glycoprotein Revenue Market Share Forecast by Regions (2021-2026)
Table 101. North America: Respiratory Syncytial Virus Attachment Glycoprotein Sales Forecast by Country (2021-2026) (K Pcs)
Table 102. North America: Respiratory Syncytial Virus Attachment Glycoprotein Revenue Forecast by Country (2021-2026) (US$ Million)
Table 103. Europe: Respiratory Syncytial Virus Attachment Glycoprotein Sales Forecast by Country (2021-2026) (K Pcs)
Table 104. Europe: Respiratory Syncytial Virus Attachment Glycoprotein Revenue Forecast by Country (2021-2026) (US$ Million)
Table 105. Asia Pacific: Respiratory Syncytial Virus Attachment Glycoprotein Sales Forecast by Region (2021-2026) (K Pcs)
Table 106. Asia Pacific: Respiratory Syncytial Virus Attachment Glycoprotein Revenue Forecast by Region (2021-2026) (US$ Million)
Table 107. Latin America: Respiratory Syncytial Virus Attachment Glycoprotein Sales Forecast by Country (2021-2026) (K Pcs)
Table 108. Latin America: Respiratory Syncytial Virus Attachment Glycoprotein Revenue Forecast by Country (2021-2026) (US$ Million)
Table 109. Middle East and Africa: Respiratory Syncytial Virus Attachment Glycoprotein Sales Forecast by Country (2021-2026) (K Pcs)
Table 110. Middle East and Africa: Respiratory Syncytial Virus Attachment Glycoprotein Revenue Forecast by Country (2021-2026) (US$ Million)
Table 111. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 112. Key Challenges
Table 113. Market Risks
Table 114. Main Points Interviewed from Key Respiratory Syncytial Virus Attachment Glycoprotein Players
Table 115. Respiratory Syncytial Virus Attachment Glycoprotein Customers List
Table 116. Respiratory Syncytial Virus Attachment Glycoprotein Distributors List
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Respiratory Syncytial Virus Attachment Glycoprotein Product Picture
Figure 2. Global Respiratory Syncytial Virus Attachment Glycoprotein Sales Market Share by Type in 2020 & 2026
Figure 3. VIS-RSV Product Picture
Figure 4. TRL-3D3 Product Picture
Figure 5. AX-14 Product Picture
Figure 6. MVA-RSV Product Picture
Figure 7. Others Product Picture
Figure 8. Global Respiratory Syncytial Virus Attachment Glycoprotein Sales Market Share by Application in 2020 & 2026
Figure 9. Clinic
Figure 10. Hospital
Figure 11. Others
Figure 12. Respiratory Syncytial Virus Attachment Glycoprotein Report Years Considered
Figure 13. Global Respiratory Syncytial Virus Attachment Glycoprotein Market Size 2015-2026 (US$ Million)
Figure 14. Global Respiratory Syncytial Virus Attachment Glycoprotein Sales 2015-2026 (K Pcs)
Figure 15. Global Respiratory Syncytial Virus Attachment Glycoprotein Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Respiratory Syncytial Virus Attachment Glycoprotein Sales Market Share by Region (2015-2020)
Figure 17. Global Respiratory Syncytial Virus Attachment Glycoprotein Sales Market Share by Region in 2019
Figure 18. Global Respiratory Syncytial Virus Attachment Glycoprotein Revenue Market Share by Region (2015-2020)
Figure 19. Global Respiratory Syncytial Virus Attachment Glycoprotein Revenue Market Share by Region in 2019
Figure 20. Global Respiratory Syncytial Virus Attachment Glycoprotein Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Respiratory Syncytial Virus Attachment Glycoprotein Revenue in 2019
Figure 22. Respiratory Syncytial Virus Attachment Glycoprotein Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Respiratory Syncytial Virus Attachment Glycoprotein Sales Market Share by Type (2015-2020)
Figure 24. Global Respiratory Syncytial Virus Attachment Glycoprotein Sales Market Share by Type in 2019
Figure 25. Global Respiratory Syncytial Virus Attachment Glycoprotein Revenue Market Share by Type (2015-2020)
Figure 26. Global Respiratory Syncytial Virus Attachment Glycoprotein Revenue Market Share by Type in 2019
Figure 27. Global Respiratory Syncytial Virus Attachment Glycoprotein Market Share by Price Range (2015-2020)
Figure 28. Global Respiratory Syncytial Virus Attachment Glycoprotein Sales Market Share by Application (2015-2020)
Figure 29. Global Respiratory Syncytial Virus Attachment Glycoprotein Sales Market Share by Application in 2019
Figure 30. Global Respiratory Syncytial Virus Attachment Glycoprotein Revenue Market Share by Application (2015-2020)
Figure 31. Global Respiratory Syncytial Virus Attachment Glycoprotein Revenue Market Share by Application in 2019
Figure 32. North America Respiratory Syncytial Virus Attachment Glycoprotein Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Respiratory Syncytial Virus Attachment Glycoprotein Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Respiratory Syncytial Virus Attachment Glycoprotein Sales Market Share by Country in 2019
Figure 35. North America Respiratory Syncytial Virus Attachment Glycoprotein Revenue Market Share by Country in 2019
Figure 36. U.S. Respiratory Syncytial Virus Attachment Glycoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Respiratory Syncytial Virus Attachment Glycoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Respiratory Syncytial Virus Attachment Glycoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Respiratory Syncytial Virus Attachment Glycoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Respiratory Syncytial Virus Attachment Glycoprotein Market Share by Type in 2019
Figure 41. North America Respiratory Syncytial Virus Attachment Glycoprotein Market Share by Application in 2019
Figure 42. Europe Respiratory Syncytial Virus Attachment Glycoprotein Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Respiratory Syncytial Virus Attachment Glycoprotein Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Respiratory Syncytial Virus Attachment Glycoprotein Sales Market Share by Country in 2019
Figure 45. Europe Respiratory Syncytial Virus Attachment Glycoprotein Revenue Market Share by Country in 2019
Figure 46. Germany Respiratory Syncytial Virus Attachment Glycoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Respiratory Syncytial Virus Attachment Glycoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Respiratory Syncytial Virus Attachment Glycoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Respiratory Syncytial Virus Attachment Glycoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Respiratory Syncytial Virus Attachment Glycoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Respiratory Syncytial Virus Attachment Glycoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Respiratory Syncytial Virus Attachment Glycoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Respiratory Syncytial Virus Attachment Glycoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Respiratory Syncytial Virus Attachment Glycoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Respiratory Syncytial Virus Attachment Glycoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Respiratory Syncytial Virus Attachment Glycoprotein Market Share by Type in 2019
Figure 57. Europe Respiratory Syncytial Virus Attachment Glycoprotein Market Share by Application in 2019
Figure 58. Asia Pacific Respiratory Syncytial Virus Attachment Glycoprotein Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Respiratory Syncytial Virus Attachment Glycoprotein Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Respiratory Syncytial Virus Attachment Glycoprotein Sales Market Share by Region in 2019
Figure 61. Asia Pacific Respiratory Syncytial Virus Attachment Glycoprotein Revenue Market Share by Region in 2019
Figure 62. China Respiratory Syncytial Virus Attachment Glycoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Respiratory Syncytial Virus Attachment Glycoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Respiratory Syncytial Virus Attachment Glycoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Respiratory Syncytial Virus Attachment Glycoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Respiratory Syncytial Virus Attachment Glycoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Respiratory Syncytial Virus Attachment Glycoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Respiratory Syncytial Virus Attachment Glycoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Respiratory Syncytial Virus Attachment Glycoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Respiratory Syncytial Virus Attachment Glycoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Respiratory Syncytial Virus Attachment Glycoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Respiratory Syncytial Virus Attachment Glycoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Respiratory Syncytial Virus Attachment Glycoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Respiratory Syncytial Virus Attachment Glycoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Respiratory Syncytial Virus Attachment Glycoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Respiratory Syncytial Virus Attachment Glycoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Respiratory Syncytial Virus Attachment Glycoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Respiratory Syncytial Virus Attachment Glycoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Respiratory Syncytial Virus Attachment Glycoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Respiratory Syncytial Virus Attachment Glycoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Respiratory Syncytial Virus Attachment Glycoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Respiratory Syncytial Virus Attachment Glycoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Respiratory Syncytial Virus Attachment Glycoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Respiratory Syncytial Virus Attachment Glycoprotein Market Share by Type in 2019
Figure 85. Asia Pacific Respiratory Syncytial Virus Attachment Glycoprotein Market Share by Application in 2019
Figure 86. Latin America Respiratory Syncytial Virus Attachment Glycoprotein Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Respiratory Syncytial Virus Attachment Glycoprotein Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Respiratory Syncytial Virus Attachment Glycoprotein Sales Market Share by Country in 2019
Figure 89. Latin America Respiratory Syncytial Virus Attachment Glycoprotein Revenue Market Share by Country in 2019
Figure 90. Mexico Respiratory Syncytial Virus Attachment Glycoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Respiratory Syncytial Virus Attachment Glycoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Respiratory Syncytial Virus Attachment Glycoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Respiratory Syncytial Virus Attachment Glycoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Respiratory Syncytial Virus Attachment Glycoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Respiratory Syncytial Virus Attachment Glycoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Respiratory Syncytial Virus Attachment Glycoprotein Market Share by Type in 2019
Figure 97. Latin America Respiratory Syncytial Virus Attachment Glycoprotein Market Share by Application in 2019
Figure 98. Middle East and Africa Respiratory Syncytial Virus Attachment Glycoprotein Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Respiratory Syncytial Virus Attachment Glycoprotein Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Respiratory Syncytial Virus Attachment Glycoprotein Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Respiratory Syncytial Virus Attachment Glycoprotein Revenue Market Share by Country in 2019
Figure 102. Turkey Respiratory Syncytial Virus Attachment Glycoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Respiratory Syncytial Virus Attachment Glycoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Respiratory Syncytial Virus Attachment Glycoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Respiratory Syncytial Virus Attachment Glycoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Respiratory Syncytial Virus Attachment Glycoprotein Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Respiratory Syncytial Virus Attachment Glycoprotein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Respiratory Syncytial Virus Attachment Glycoprotein Market Share by Type in 2019
Figure 109. Middle East and Africa Respiratory Syncytial Virus Attachment Glycoprotein Market Share by Application in 2019
Figure 110. North America Respiratory Syncytial Virus Attachment Glycoprotein Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Respiratory Syncytial Virus Attachment Glycoprotein Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Respiratory Syncytial Virus Attachment Glycoprotein Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Respiratory Syncytial Virus Attachment Glycoprotein Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Respiratory Syncytial Virus Attachment Glycoprotein Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Respiratory Syncytial Virus Attachment Glycoprotein Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Respiratory Syncytial Virus Attachment Glycoprotein Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Respiratory Syncytial Virus Attachment Glycoprotein Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Respiratory Syncytial Virus Attachment Glycoprotein Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Respiratory Syncytial Virus Attachment Glycoprotein Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
呼吸器合胞体ウイルス診断の世界市場（～2026年） Products of the respiratory syncytial virus diagnostics market includes direct fluorescent antibody (DFA) method, rapid antigen diagnostic test (RADTs), molecular diagnostics, chromatographic immunoassay, diagnostic imaging, gel microdroplets, flow cytometry, and others. North America dominates the …- ヒト呼吸器合胞体ウイルス薬の世界市場（～2026年） Human respiratory syncytial virus (HRSV) is a syncytial virus that causes respiratory tract infections. It is a major cause of lower respiratory tract infections and hospital visits during infancy and childhood. A prophylactic medication, palivizumab, can be employed to prevent HRSV in preterm (unde…
- 呼吸器合胞体ウイルス（RSV）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Respiratory Syncytial Virus (RSV) Therapeutics Market The global Respiratory Syncytial Virus (RSV) Therapeutics market size is projected to reach US$ 599.6 million by 2026, from US$ 564.7 million in 2020, at a CAGR of 5.7%% during 2021-2026. Global Respiratory Sy…
- T細胞特異的表面糖タンパク質CD28の世界市場（～2026年） Market Analysis and Insights: Global T Cell Specific Surface Glycoprotein CD28 Market The global T Cell Specific Surface Glycoprotein CD28 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global T Cell Specific Surface Glycopr…
- T細胞表面糖タンパク質CD4の世界市場（～2026年） Market Analysis and Insights: Global T Cell Surface Glycoprotein CD4 Market The global T Cell Surface Glycoprotein CD4 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global T Cell Surface Glycoprotein CD4 Scope and Market Si…